Intragastric Balloon Market Registering A CAGR Of 12.1% From 2020 To 2027


 San Francisco, 8 Dec 2020: The Report Intragastric Balloon Market Size, Share & Trends Analysis Report By Administration (Pill Form, Endoscopy), By Balloon Type (Single, Dual, Triple), By Filling Material, By End Use, By Region, And Segment Forecasts, 2020 - 2027

The global intragastric balloon market size is expected to reach USD 90.5 million by 2027, expanding at a CAGR of 12.1% over the forecast period, according to a new report by Grand View Research, Inc. Rise in obesity and increasing demand for minimally invasive procedures are the key factors driving the market.

Intragastric balloons are one of the most widely adopted endoscopic bariatric therapy devices in the clinical settings. This can be attributed to complications associated with surgical weight loss treatments and the low eligibility criteria for surgical options, thus leading to a rise in demand for effective minimally invasive weight-loss treatment options.

Safety concerns associated with intragastric balloons are anticipated to make the regulatory framework more stringent for pre-market and post-market scrutiny process of these devices. For instance, in 2019, Apollo Endosurgery Inc. revised the labeling of its Orbera intragastric balloon system to include contradiction clarifications, precautions related to anticholinergic and psychotropic medications, and updated U.S. adverse event tables after it received FDA safety letter.

Nonetheless, extensive research activities related to the development of innovative and novel systems and up-gradation of existing intragastric balloons to overcome the shortcomings of the traditional systems are anticipated to facilitate the intragastric balloon market growth.

Access Research Report of Intragastric Balloon Market @ https://www.grandviewresearch.com/industry-analysis/intragastric-balloon-market

Further key findings from the study suggest:

  • According to the American Society for Metabolic and Bariatric Surgery (ASMBS) data, nearly 5,000 intragastric balloon implantations have been conducted since the U.S. FDA approval
  • The single balloon type segment held the largest share in the market in 2019. The triple type is expected to witness significant growth over the forecast period
  • By filling material, gas-filled systems are anticipated to witness lucrative growth over the forecast period
  • Based on end use, hospitals held a significant share in 2019. Ambulatory surgical centers are expected to witness considerable growth from 2020 - 2027
  • On the basis of administration, endoscopy held the dominant market share in 2019. Pill form is expected to witness lucrative growth over the forecast period
  • North America dominated the intragastric balloon market in 2019 due to the presence of a large obese population and high adoption of bariatric procedures. Asia Pacific is expected to witness remunerative growth over the forecast period
  • Some of the key companies operating in the market are Apollo Endosurgery, Inc.; Obalon Therapeutics, Inc; ReShape Medical, Inc; Allurion Technologies, Inc.; Spatz3; Helioscopie; Endalis; MEDSIL; and Lexel Medical
  • As of January 2019, Apollo Endosurgery, Inc. has discontinued the sales and distribution of its ReShape Balloon.

Browse more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the global intragastric balloon market on the basis of administration, balloon type, filling material, end use, and region:

Intragastric Balloon Administration Outlook (Revenue, USD Million, 2016 - 2027)

  • Pill Form
  • Endoscopy

Intragastric Balloon Type Outlook (Revenue, USD Million, 2016 - 2027)

  • Single
  • Dual
  • Triple

Intragastric Balloon Filling Material Outlook (Revenue, USD Million, 2016 - 2027)

  • Saline Filled
  • Gas Filled

Intragastric Balloon End-use Outlook (Revenue, USD Million, 2016 - 2027)

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers

Intragastric Balloon Regional Outlook (Revenue, USD Million, 2016 - 2027)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • MEA

Access Press Release of Intragastric Balloon Market @ https://www.grandviewresearch.com/press-release/global-intragastric-balloon-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information:www.grandviewresearch.com

Comments

Post a Comment

Popular posts from this blog

Pharmacovigilance Market Overview By Service Provider, Product Life Cycle, Type, Process Flow, Therapeutic Area, End Use, Region And Forecast

Image
  San Francisco, 5 Novembers 2025:  The Report  Pharmacovigilance Market  (2025 - 2030) Size, Share & Trends Analysis Report By Product Life Cycle, By Service Provider (In-house, Contract Outsourcing), By Type, By Therapeutic Area, By Process Flow, By End Use, By Region, And Segment Forecasts The global pharmacovigilance market size is projected to reach USD 11.78 billion by 2030, according to a new report by Grand View Research, Inc. It is anticipated to witness growth at a CAGR of 6.5% from 2025 to 2030. The key factor responsible for the market growth is the growing incidence of Adverse Drug Reactions (ADR). ADR imposes a significant load on healthcare systems and is one of the evident grounds for morbidity in developed nations. As per the National Center for Biotechnology Information (NCBI), about 1 in 20 hospitalizations in Europe yearly are owing to ADR. Pharmacovigilance (PV) services play a vital role in the clinical trial phase by aiding manufacturers in...
Read more

Allergy Diagnostics Market Size Is Expected To Reach USD 11.63 Billion By 2030

Image
  San Francisco, 17 Novembers 2025:  The Report  Allergy Diagnostics Market  (2025 - 2030) Size, Share & Trends Analysis Report By Products And Services (Instruments, Consumables), By Allergen (Food, Inhaled, Drugs), By Test Type (In Vivo Test, In Vitro Test), By End Use (Hospital & Clinics), By Region, And Segment Forecasts The global allergy diagnostics market size is expected to reach USD 11.63 billion by 2030, registering a CAGR of 10.39% from 2025 to 2030, according to a new report by Grand View Research, Inc. Allergies continue to be a significant public health concern in the U.S. and worldwide, affecting both children and adults across all demographics. According to the CDC’s 2023 National Health Interview Survey (NHIS), approximately 25.7% of adults and 18.9% of children in the U.S. reported being diagnosed with seasonal allergies, eczema, or food allergies. This data highlights the growing prevalence of allergic conditions, reflecting an ur...
Read more

Veterinary Services Market Projected To Raise At USD 212.73 Billion By 2030

Image
  San Francisco, 31 January 2025:  The Report  Veterinary Services Market  Size, Share & Trends Analysis Report By Service Type (Non-medical, Medical), By Animal Type (Companion, Production), By Region, And Segment Forecasts, 2023 - 2030 The global veterinary services market size is projected to reach USD 212.73 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to grow at a CAGR of 7.45% from 2023 to 2030.Some of the key factors propelling the market growth include increasing animal welfare activities, the rising need to enhance food security, increasing pet population, growing awareness about animal health & timely diagnosis & treatments, and increasing expenditure on animal healthcare services. For instance, according to the American Pet Products Association (APPA), overall spending in the U.S. pet industry was estimated at USD 136.8 billion in 2022. This was notably greater than the USD 123.6 billi...
Read more